The recent Coronary Microvascular Angina (CorMicA) trial revealed that patients may benefit when coronary microvascular dysfunction is accurately diagnosed and appropriately treated:1
27%
Sustained Angina Improvement with CMD Treatment
† According to the Seattle Angina Questionnaire score.
The CorMicA study data1 reveals that adequate evaluation and optimal treatment of patients who have ischemia with non-obstructive coronary arteries (INOCA) can:
When patients are diagnosed and treated in fewer cath lab visits, overall healthcare costs may be reduced accordingly.
The PressureWire™ X Guidewire and Coroventis‡ CoroFlow‡ Cardiovascular System can measure both IMR and CFR - allowing for a CMD diagnosis.2
Having a comprehensive physiology testing of both the epicardial arteries and microcirculation can provide clear diagnosis to guide treatment and outcomes.3
How to measure IMR
Allen Jeremias, MD, New York, USA
MAT-2006712 v1.0
Indications: CoroFlow‡ is indicated to provide hemodynamic information for use in the diagnosis of patients with cardiovascular diseases.
CoroFlow‡ is intended for use in catheterization and related cardiovascular specialty laboratories to compute and display various physiological parameters based on the output from one or more measuring devices.
Contraindications: The system has no patient alarm functions. Do not use for cardiac/vital signs monitoring.
Warnings:
Precautions:
Indications: The PressureWire™ X Guidewire is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessels. Physiological parameters include blood pressure. The PressureWire™ X Guidewire can also measure blood temperature.
Contraindications: This guidewire is contraindicated for use in the cerebral vasculature.
Warnings:
Precautions:
Potential Adverse Events: Potential complications which may be encountered during all catheterization procedures include, but are not limited to: vessel dissection or occlusion, perforation, embolus, spasm, local and/or systemic infection, pneumothorax, congestive heart failure, myocardial infarction, hypotension, chest pain, renal insufficiency, serious arrhythmias, or death.
MAT-2103602 v1.0